Recurrent Glioblastoma, IDH-Wildtype

specific

The reemergence of glioblastoma, IDH-wildtype after a period of remission.

27

Centers

18

Active Trials

Cancer Funding

Top Centers for Recurrent Glioblastoma, IDH-Wildtype(27)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
59.4
2
NCI Comprehensive
Active Research Program
59.4
3
NCI Comprehensive
Active Research Program
59.4
4
NCI Comprehensive
Active Research Program
59.4
5
NCI Comprehensive
Active Research Program
59.4
6
NCI Comprehensive
Active Research Program
59.4
7
NCI Comprehensive
Active Research Program
59.4
859.4
9
NCI Comprehensive
Active Research Program
59.4
10
NCI Comprehensive
Active Research Program
59.4
11
NCI Comprehensive
Active Research Program
59.4
12
NCI Comprehensive
Active Research Program
59.4
13
NCI Clinical
Active Research Program
59.4
14
NCI Comprehensive
Active Research Program
59.4
15
NCI Comprehensive
Active Research Program
59.4
16
Active Research Program
59.4
17
Active Research Program
59.4
18
Active Research Program
59.4
19
NCI Comprehensive
36.9
20
NCI Comprehensive
36.9
21
NCI Comprehensive
36.9
22
NCI Comprehensive
36.9
23
NCI Comprehensive
36.9
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
36.9
2536.9
2636.9
2736.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →